TABLE 5.
NVC parameters (p‐value) | SCORE2 (OPT) | AE | Severity | Disease duration | History or presence of AID | ASST | Inflammation markers | EC markers | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CRP | ESR | Anemia | VEGF | SCF | sE‐selectin | |||||||
Capillary density | 0.94 | 0.45 | 0.08 | 0.50 | 0.87 | 0.72 | 0.41 | 0.64 | 0.23 | 0.30 | 0.79 | 0.49 |
Normal cap | 0.95 | 0.81 | 0.11 | 0.75 | 0.97 | 0.91 | 0.13 | 0.34 | 0.044 | 0.035 | 0.53 | 0.56 |
Total abnormal cap | 0.71 | 0.28 | 0.92 | 0.48 | 0.66 | 0.33 | 0.10 | 0.26 | 0.054 | 0.019 | 0.44 | 0.90 |
%Abnormal/total nb cap | 0.79 | 0.33 | 0.79 | 0.51 | 0.63 | 0.51 | 0.059 | 0.21 | 0.038 | 0.004 | 0.48 | 0.89 |
Ramified cap | 0.80 | 0.59 | 0.29 | 0.86 | 0.047 | 0.63 | 0.52 | 0.21 | 0.059 | 0.39 | 0.69 | 0.55 |
%Ramified/total nb cap | 1.00 | 0.70 | 0.17 | 0.90 | 0.005 | 0.55 | 0.29 | 0.58 | 0.50 | 0.80 | 0.47 | 0.63 |
Concave cap | 0.40 | 0.80 | 0.76 | 0.38 | 0.41 | 0.72 | 0.35 | 0.50 | 0.75 | 0.25 | 0.96 | 0.80 |
%Concave/total nb cap | 0.58 | 0.92 | 0.24 | 0.07 | 0.39 | 0.59 | 0.86 | 0.32 | 0.49 | 0.10 | 0.83 | 0.91 |
Crossing cap | 1.00 | 0.30 | 0.64 | 0.19 | 0.33 | 0.36 | 0.12 | 0.60 | 0.15 | 0.019 | 0.37 | 0.81 |
%Crossing/total nb cap | 0.63 | 0.85 | 0.92 | 0.11 | 0.18 | 0.91 | 0.38 | 0.69 | 0.92 | 0.13 | 0.79 | 0.75 |
Regularly enlarged cap | 0.41 | 0.83 | 0.47 | 0.67 | 0.049 | 0.71 | 0.24 | 0.12 | 0.66 | 0.07 | 0.84 | 0.07 |
Irregularly enlarged cap | 0.80 | 0.52 | 0.47 | 0.82 | 0.31 | 0.71 | 0.47 | 0.14 | 0.96 | 0.74 | 0.47 | 0.043 |
Giant cap | ND | 0.46 | ND | ND | 0.69 | 0.19 | ND | ND | ND | ND | ND | ND |
total nb of dilated cap | 0.51 | 1.00 | 0.67 | 0.67 | 0.048 | 0.68 | 0.23 | 0.08 | 0.70 | 0.15 | 0.97 | 0.032 |
%nb dil/total nb cap | 0.50 | 0.93 | 0.53 | 0.96 | 0.07 | 0.73 | 0.24 | 0.10 | 0.84 | 0.18 | 0.92 | 0.055 |
Microhemorrhages | 0.19 | 0.81 | 0.70 | 0.76 | 0.22 | 0.79 | 0.51 | 0.49 | 0.65 | 0.95 | 0.21 | 0.42 |
NVC plexus score | 0.95 | 0.72 | 0.97 | 0.39 | 0.67 | 0.49 | 0.16 | 0.58 | 0.64 | 0.75 | 0.65 | 0.88 |
Note: NVC parameters and their clinico‐serological associations are given using multiple regressions analyses, including age as a covariate and sex as a factor. p‐values are considered statistically significant when p < 0.05 (bold). Standard definitions of capillaroscopic evaluations suggested by the European League Against Rheumatism study group on microcirculation in rheumatic diseases (EULAR SG MC/RD) were applied 7 , 38 . Capillary crossings were considered abnormal when >2 crossings were observed. The total number of abnormal shapes corresponded with the sum of all capillaries with multiple crossings (>2), ramifications and concave tips.
Abbreviations: AE, angioedema; AID, auto‐immune diseases; ASST, autologous serum skin test; cap, capillaries; CRP, C reactive protein; CSU, chronic spontaneous urticaria; EC, endothelial cell; ESR, erythrocyte sedimentation rate; nb, number; NS, not significant; NVC, nailfold videocapillaroscopy; SCF, stem cell factor; VEGF, vascular endothelial growth factor.